Palomino Laboratories (PALX) Consolidated Net Income (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of Consolidated Net Income data on file, last reported at -$1.6 million in Q3 2025.

• For the quarter ending Q3 2025, Consolidated Net Income fell 143536.85% year-over-year to -$1.6 million; the trailing twelve-month figure through Dec 2025 stood at -$1.7 million (down 565.15% YoY), and the FY2024 full-year result was -$145866.0, down 22.73% from the prior year.
• Consolidated Net Income retreated to -$1.6 million in Q3 2025, from -$43775.0 in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of -$1118.0 in Q3 2024 to a low of -$1.6 million in Q3 2025.
• A 3-year average of -$226325.9 and a median of -$51304.0 in 2024 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income surged 97.39% in 2024 and sank 143536.85% in 2025, its largest moves.
• Tracing PALX's Consolidated Net Income over 3 years: stood at -$67487.0 in 2023, then tumbled by 102.91% to -$136938.0 in 2024, then slumped by 1072.69% to -$1.6 million in 2025.
• Business Quant data shows PALX's Consolidated Net Income at -$1.6 million in Q3 2025, -$43775.0 in Q2 2025, and -$25156.0 in Q1 2025.